These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 24172242)
1. Preparation and optimization of triptolide-loaded solid lipid nanoparticles for oral delivery with reduced gastric irritation. Zhang C; Gu C; Peng F; Liu W; Wan J; Xu H; Lam CW; Yang X Molecules; 2013 Oct; 18(11):13340-56. PubMed ID: 24172242 [TBL] [Abstract][Full Text] [Related]
2. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats. Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813 [TBL] [Abstract][Full Text] [Related]
3. Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats. Zhang C; Peng F; Liu W; Wan J; Wan C; Xu H; Lam CW; Yang X Int J Nanomedicine; 2014; 9():1049-63. PubMed ID: 24591827 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, Characterization, and Evaluation of Triptolide Cell-Penetrating Peptide Derivative for Transdermal Delivery of Triptolide. Tian T; Song Y; Li K; Sun Y; Wang Q Mol Pharm; 2018 Feb; 15(2):560-570. PubMed ID: 29307194 [TBL] [Abstract][Full Text] [Related]
5. The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle. Mei Z; Li X; Wu Q; Hu S; Yang X Pharmacol Res; 2005 Apr; 51(4):345-51. PubMed ID: 15683748 [TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Mei Z; Chen H; Weng T; Yang Y; Yang X Eur J Pharm Biopharm; 2003 Sep; 56(2):189-96. PubMed ID: 12957632 [TBL] [Abstract][Full Text] [Related]
7. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis. Gu Y; Tang X; Yang M; Yang D; Liu J Int J Pharm; 2019 Jan; 554():235-244. PubMed ID: 30423415 [TBL] [Abstract][Full Text] [Related]
8. Triptolide-nanoliposome-APRPG, a novel sustained-release drug delivery system targeting vascular endothelial cells, enhances the inhibitory effects of triptolide on laser-induced choroidal neovascularization. Lai K; Li Y; Gong Y; Li L; Huang C; Xu F; Zhong X; Jin C Biomed Pharmacother; 2020 Nov; 131():110737. PubMed ID: 32932044 [TBL] [Abstract][Full Text] [Related]
9. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms. Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085 [TBL] [Abstract][Full Text] [Related]
10. Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity. Zheng W; Wang C; Ding R; Huang Y; Li Y; Lu Y Int J Pharm; 2019 Dec; 572():118721. PubMed ID: 31626922 [TBL] [Abstract][Full Text] [Related]
11. Triptolide loaded solid lipid nanoparticle hydrogel for topical application. Mei Z; Wu Q; Hu S; Li X; Yang X Drug Dev Ind Pharm; 2005 Jan; 31(2):161-8. PubMed ID: 15773283 [TBL] [Abstract][Full Text] [Related]
12. [Preparation and toxicity of triptolide-loaded poly (D,L-lactic acid) nanoparticles]. Liu MX; Dong J; Yang YJ; Yang XL; Xu HB Yao Xue Xue Bao; 2004 Jul; 39(7):556-60. PubMed ID: 15493850 [TBL] [Abstract][Full Text] [Related]
13. Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles. Liu J; Cheng H; Han L; Qiang Z; Zhang X; Gao W; Zhao K; Song Y Drug Des Devel Ther; 2018; 12():3199-3209. PubMed ID: 30288024 [TBL] [Abstract][Full Text] [Related]
15. Lipid nanoparticles loading triptolide for transdermal delivery: mechanisms of penetration enhancement and transport properties. Gu Y; Yang M; Tang X; Wang T; Yang D; Zhai G; Liu J J Nanobiotechnology; 2018 Sep; 16(1):68. PubMed ID: 30217198 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tissue distribution study in mice of triptolide-loaded lipid emulsion and accumulation effect on pancreas. Li X; Mao Y; Li K; Shi T; Yao H; Yao J; Wang S Drug Deliv; 2016 May; 23(4):1344-54. PubMed ID: 25853479 [TBL] [Abstract][Full Text] [Related]
17. Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo. Zhang L; Wang T; Li Q; Huang J; Xu H; Li J; Wang Y; Liang Q Int J Nanomedicine; 2016; 11():2663-73. PubMed ID: 27354796 [TBL] [Abstract][Full Text] [Related]
18. Inflammation-Responsive Mesoporous Silica Nanoparticles with Synergistic Anti-inflammatory and Joint Protection Effects for Rheumatoid Arthritis Treatment. Wu YZ; Chen WY; Zeng Y; Ji QL; Yang Y; Guo XL; Wang X Pharm Res; 2024 Jul; 41(7):1493-1505. PubMed ID: 38918308 [TBL] [Abstract][Full Text] [Related]
19. A study of microemulsion systems for transdermal delivery of triptolide. Chen H; Chang X; Weng T; Zhao X; Gao Z; Yang Y; Xu H; Yang X J Control Release; 2004 Aug; 98(3):427-36. PubMed ID: 15312998 [TBL] [Abstract][Full Text] [Related]
20. Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes. Yuan ZX; Jia L; Lim LY; Lin JC; Shu G; Zhao L; Ye G; Liang XX; Ji H; Fu HL Int J Nanomedicine; 2017; 12():5673-5686. PubMed ID: 28848346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]